Progestin inhibition of cell death in human breast cancer cell lines

Journal of Steroid Biochemistry and Molecular Biology

Volumn 98, Issue 4-5, 2006, Pages 218-227

  Moore, Michael R ^a   Spence, James B ^a   Kiningham, Kelley K ^a   Dillon, Joshua L ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Breast cancer; Chemotherapy; Estrogen; Progesterone

Indexed keywords

ANTIGESTAGEN; ESTRADIOL; GESTAGEN; MIFEPRISTONE; PROGESTERONE RECEPTOR;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL DEATH; CELL STRAIN MCF 7; DRUG INHIBITION; HORMONE INHIBITION; HUMAN; HUMAN CELL;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BREAST NEOPLASMS; DOXORUBICIN; ESTRADIOL; FEMALE; FLUOROURACIL; HUMANS; PROGESTINS; RECEPTORS, PROGESTERONE; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 33644747380     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.09.008     Document Type: Article

References (54)

1. W.L. McGuire, G.C. Chamness, M.E. Costlow, and R.E. Shepherd Hormone dependence in breast cancer Metabolism 23 1974 75 100
2. M. Lippman, G. Bolan, and K. Huff The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long term tissue culture Cancer Res. 36 1976 4595 4601
3. J. Bryant, B. Fisher, and J. Dignam Duration of adjuvant tamoxifen therapy J. Natl. Cancer Inst. Monogr. 30 2001 56 61
4. K.B. Horwitz, and G.R. Friedenberg Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47Dco human breast cancer cells by progestins: implications for endocrine therapies Cancer Res. 45 1985 167 173
5. R. Poulin, J.M. Dufour, and F. Labrie Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cells: antagonism by insulin Breast Cancer Res. Treat. 13 1989 265 276
6. E.A. Musgrove, C.S.L. Lee, and R.L. Sutherland Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor α, epidermal growth factor receptor, c-fos and c-myc genes Mol. Cell. Biol. 11 1991 5032 5043
7. S.D. Groshong, G.I. Owen, B. Grimison, I.E. Schauer, M.C. Todd, T.A. Langan, R.A. Sclafani, C.A. Lange, and K.B. Horwitz Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27Kip1 Mol. Endocrinol. 11 1997 1593 1607
8. F. Vignon, S. Bardon, D. Chalbos, and H. Rochefort Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture J. Clin. Endocr. Metab. 56 1983 1124 1130
9. J.R. Hissom, and M.R. Moore Progestin effects on growth in the human breast cancer cell line T47D - possible therapeutic implications Biochem. Biophys. Res. Commun. 145 1987 706 711
10. A. Manni, B. Badger, C. Wright, S.R. Ahmed, and L.M. Dehmers Effects of progestins on growth of experimental breast cancer in culture: interaction with estradiol and prolactin and involvement of the polyamine pathway Cancer Res. 47 1987 3066 3071
11. Y.E. Shi, Y.E. Liu, M.E. Lippman, and R.B. Dickson Progestins and antiprogestins in mammary tumor growth and metastasis Human Reprod. 9 Suppl. 1 1994 162 173
12. C.A. Lange, J.K. Richer, and K.B. Horwitz Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or anti-proliferative signals Mol. Endocrinol. 13 1999 829 836
13. A. Migliaccio, D. Piccolo, G. Castoria, M. Di Domenico, A. Bilancio, M. Lombardi, W. Gong, M. Beato, and F. Auricchio Activation of the src/p21ras/erk pathway by progesterone receptor via cross-talk With estrogen receptor EMBO J. 17 1998 2008 2018
14. M.R. Moore, R.D. Hagley, and J.R. Hissom Progestin effects on lactate dehydrogenase and growth in the human breast cancer cell line T47D W.D. Hankins D. Puett Progress in Clinical and Biological Research 262 1988 Liss New York 161 179
15. J.R. Hissom, R.T. Bowden, and M.R. Moore Effects of progestins, estrogens and antihormones on growth and lactate dehydrogenase in the human breast cancer cell line T47D Endocrinology 125 1989 418 423
16. R.T. Bowden, J.R. Hissom, and M.R. Moore Growth stimulation of T47D human breast cancer cells by the antiprogestin RU486 Endocrinology 124 1989 2642 2644
17. M.R. Moore, L.D. Hathaway, and J.A. Bircher Progestin stimulation of thymidine kinase in the human breast cancer cell line T47D Biochim. Biophys. Acta 1096 1991 170 174
18. M.R. Moore, J. Zhou, K.A. Blankenship, J.S. Strobl, D.P. Edwards, and R.N. Gentry A sequence in the 5′ flanking region confers progestin responsiveness on the human c-myc gene J. Steroid Biochem. Mol. Biol. 62 1997 243 252
19. M.R. Moore, J.L. Conover, and K.M. Franks Progestin effects on long-term growth, death, and bcl-xL in breast cancer cells Biochem. Biophys. Res. Commun. 277 2000 650 654
20. K. Ory, J. LeBeau, C. Levalois, K. Bishay, P. Fouchet, I. Allemand, A. Therwath, and S. Chevillard Apoptosis inhibition mediated by medroxyprogesterone acetate treatment of breast cancer cell lines Breast Cancer Res. Treat. 68 2001 187 198
21. C. Schairer, J. Lubin, R. Troisi, S. Sturgeon, L. Brinton, and R. Hoover Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk JAMA 283 2000 485 491
22. I. Persson, E. Weiderpass, L. Bergkvist, R. Bergstrom, and C. Schairer Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement Cancer Causes Contr. 10 1999 253 260
23. R.K. Ross, P.C.W. Paganini-Hill, and M.C. Pike Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin J. Natl. Cancer Inst. 92 2000 328 332
24. C.I. Li, N.S. Weiss, J.L. Stanford, and J.R. Daling Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women Cancer 88 2000 2570 2577
25. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial JAMA 288 2002 321 333
26. J.P. Lydon, G. Ge, F.S. Kittrell, D. Medina, and B. O'Malley Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function Cancer Res. 59 1999 4276 4284
27. Million Women Study Collaborators Breast cancer and hormone-replacement therapy in the million women study Lancet 362 2003 419 427
28. M.L. Berg, A.M. Dharmarajan, and B.J. Waddell Glucocorticoids and progesterone prevent apoptosis in the lactating mammary gland Endocrinology 143 2002 222 227
29. Z. Feng, A. Marti, B. Jehn, H.J. Altermatt, G. Chicaiza, and R. Jaggi Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland J. Cell Biol. 131 1995 1095 1103
30. T.J. Moran, S. Gray, C.A. Mikosz, and S.D. Conzen The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells Cancer Res. 60 2000 867 872
31. M.K.T. Squier, and J.J. Cohen Cohen: standard quantitative assays for apoptosis Mol. Biotechnol. 19 2001 305 312
32. J.D. Dignam, R.M. Lebovitz, and R.G. Roeder Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei Nucl. Acids Res. 11 1983 1475 1489
33. R.B. Evans-Storms, and J.A. Cidlowski Delineation of an antiapoptotic action of glucocorticoids in hepatoma cells: the role of nuclear factor-κB Endocrinology 141 2000 1854 1862
34. V.A. Tovar-Sepulveda, X. Shen, and M. Falzon Intracrine PTHrP protects against serum-starvation-induced apoptosis and regulates the cell cycle in MCF-7 breast cancer cells Endocrinology 143 2002 596 606
35. J. Yu, S. Tian, L. Metheny-Barlow, L.-J. Chew, A.J. Hayes, H. Pan, G.-L. Yu, and L.-Y. Li Modulation of endothelial cell growth arrest and apoptosis by vascular endothelial growth inhibitor Circ. Res. 89 2001 1161 1167
36. K.B. Horwitz, D.T. Zava, A.K. Thilagar, E.M. Jensen, and W.L. McGuire Steroid receptor analyses of nine human breast cancer cell lines Cancer Res. 38 1978 2434 2437
37. D.L. Clemm, L. Sherman, V. Boonyaratanakornkit, W.T. Schrader, N.L. Weigel, and D.P. Edwards Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody Mol. Endocrinol. 14 2000 52 65
38. G.P. Vicent, G. Burton, A. Ghini, C.P. Lantos, and M.D. Galisniana Influence of calf serum on glucocorticoid responses of certain progesterone derivatives J. Steroid Biochem. Mol. Biol. 66 1998 211 216
39. A.G. Porter, and R.U. Janicke Emerging roles of caspase-3 in apoptosis Cell Death Differ. 6 1999 99 104
40. A. Danilkovitch, S. Donley, A. Skeel, and E.J. Leonard Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cells Mol. Cell. Biol. 20 2000 2218 2227
41. J.J. Peluso Progesterone as a regulator of granulosa cell viability J Steroid Biochem. Mol. Biol. 85 2003 167 173
42. B. Formby, and T.S. Wiley Bcl-2, survivin and variant CD44 v7-v10 are downregulated and P53 is upregulated in breast cancer cells by progesterone: inhibition of cell growth and induction of apoptosis Mol. Cell. Biochem. 202 1999 53 61
43. A. Gompel, S. Somai, M. Chaouat, A. Kazem, H.J. Kloosterboer, I. Beusman, P. Forgez, M. Mimoun, and W. Rostene Hormonal regulation of apoptosis in breast cells and tissues Steroids 65 2000 593 598
44. C.L. Clarke, and R.L. Sutherland Progestin regulation of cellular proliferation Endocr. Rev. 11 1990 266 301
45. Y. Berthois, J.A. Katzenellenbogen, and B.S. Katzenellenbogen Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture Proc. Natl. Acad. Sci. U.S.A. 83 1986 2496 2500
46. G. Bunone, P.A. Briand, R.J. Miksicek, and D. Picard Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation EMBO J. 15 1996 2174 2183
47. E.M. Apostolakis, J. Garai, J.E. Lohmann, J.H. Clark, and B.W. O'Malley Epidermal growth factor activates reproductive behavior independent of ovarian steroids in female rodents Mol. Endocrinol. 14 2000 1086 1098
48. D.P. Rose, K. Tilton, H. Lahti, and E.L. Wynder Progesterone levels in breast duct fluid Eur. J. Cancer Clin. Oncol. 22 1986 111 113
49. N. Kyprianou, H.F. English, N.E. Davidson, and J.T. Isaacs Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation Cancer Res. 51 1991 162 166
50. R.X.-D. Song, and R.J. Santen Apoptotic action of estrogen Apoptosis 8 2003 55 60
51. C. Ruiz-Ruiz, G. Robledo, E. Cano, J.M. Redondo, and A. Lopez-Rivas Characterization of p53-mediated upregulation of CD95 gene expression upon genotoxic treatment in human breast tumor cells J. Biol. Chem. 278 2003 31667 31675
52. United States Pharmacopoeial Convention, Inc. Drug information for the health care professional 2000 Micromedex, Inc. pp. 1355-1364
53. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
54. S. Krajewski, M. Krajewska, B.C. Turner, C. Pratt, B. Howard, V.M. Zapata, V. Frenkel, S. Robertson, Y. Ionov, H. Yamamoto, M. Perucho, S. Takayama, and J.C. Reed Prognostic significance of apoptosis regulators in breast cancer Endocr. Relat. Cancer 6 1999 29 40